Delivery Order SPE2DB24D3013-SPE2DB25FFKZS

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,088.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Mounjaro 10 mg/0.5 ml pen 0.5 ml, with a completion date of February 7, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,111.27, is a Firm Fixed Price Delivery Order for the supply of Mounjaro 10 mg/0.5 ml pens. It has an ultimate completion date of July 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,578.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor. The contract is for the delivery of the medication Mounjaro (12.5 mg/0.5 ml pen, 0.5 ml) to support military treatment facilities and programs. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is September 13, 2024. The contract is not designated as a set-aside....
This federal contract award, valued at $1,317.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Mounjaro 10 mg/0.5 ml pen. The contract is a firm fixed-price delivery order with an ultimate completion date of April 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,765.25, is for the delivery of Mounjaro 2.5 mg/0.5 ml pens. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of September 10, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds significant Indefinite Delivery...
This federal contract award, valued at $3,517.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 23, 2024. This award is not associated with a set-aside program. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mounjaro 12.5 mg/0.5 ml pens. The $2,034.92 firm fixed-price delivery order is for products to be delivered by May 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,904.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Mounjaro 7.5 mg/0.5 ml pen, 0.5 ml, with a performance period ending on April 11, 2025. This delivery order is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $3,265.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Mounjaro, a 5 mg/0.5 ml medication pen, with a performance period extending through April 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,930.20, is for the delivery of Mounjaro 10 mg/0.5 ml pens. This is a firm fixed-price delivery order contract with a period of performance through July 2, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFKZS
    Delivery Order

This federal contract award, valued at $1,088.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro, a 2.5 mg/0.5 ml pharmaceutical pen, with an ultimate completion date of April 18, 2025.

The contract is a delivery order, with a firm fixed-price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract positions Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/17/25, 2:11 PM